Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin. 2002

László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. viraglaszlo@hotmail.com

In the last decade it has become well established that in the skin, nitric oxide (NO), a diffusable gas, mediates various physiologic functions ranging from the regulation of cutaneous blood flow to melanogenesis. If produced in excess, NO combines with superoxide anion to form peroxynitrite (ONOO-), a cytotoxic oxidant that has been made responsible for tissue injury during shock, inflammation and ischemia-reperfusion. The opposite effects of NO and ONOO- on various cellular processes may explain the 'double-edged sword' nature of NO depending on whether or not cellular conditions favour peroxynitrite formation. Peroxynitrite has been shown to activate the nuclear nick sensor enzyme, poly(ADP-ribose) polymerase (PARP). Overactivation of PARP depletes the cellular stores of NAD+, the substrate of PARP, and the ensuing 'cellular energetic catastrophy' results in necrotic cell death. Whereas the role of NO in numerous skin diseases including wound healing, burn injury, psoriasis, irritant and allergic contact dermatitis, ultraviolet (UV) light-induced sunburn erythema and the control of skin infections has been extensively documented, the intracutaneous role of peroxynitrite and PARP has not been fully explored. We have recently demonstrated peroxynitrite production, DNA breakage and PARP activation in a murine model of contact hypersensitivity, and propose that the peroxynitrite-PARP route represents a common pathway in the pathomechanism of inflammatory skin diseases. Here we briefly review the role of NO in skin pathology and focus on the possible roles played by peroxynitrite and PARP in various skin diseases.

UI MeSH Term Description Entries
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D011064 Poly Adenosine Diphosphate Ribose A polynucleotide formed from the ADP-RIBOSE moiety of nicotinamide-adenine dinucleotide (NAD) by POLY(ADP-RIBOSE) POLYMERASES. Poly ADP Ribose,Poly(ADP-Ribose),Poly-ADPR,Poly-Adenosine Diphosphate-Ribose,ADP Ribose, Poly,Diphosphate-Ribose, Poly-Adenosine,Poly ADPR,Ribose, Poly ADP
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012879 Skin Physiological Phenomena The functions of the skin in the human and animal body. It includes the pigmentation of the skin. Skin Physiological Processes,Skin Physiology,Physiology, Skin,Skin Physiological Concepts,Skin Physiological Phenomenon,Skin Physiological Process,Concept, Skin Physiological,Concepts, Skin Physiological,Phenomena, Skin Physiological,Phenomenas, Skin Physiological,Phenomenon, Skin Physiological,Phenomenons, Skin Physiological,Physiological Concept, Skin,Physiological Concepts, Skin,Physiological Phenomena, Skin,Physiological Phenomenas, Skin,Physiological Phenomenon, Skin,Physiological Phenomenons, Skin,Process, Skin Physiological,Processes, Skin Physiological,Skin Physiological Concept,Skin Physiological Phenomenas,Skin Physiological Phenomenons
D016877 Oxidants Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). Oxidant,Oxidizing Agent,Oxidizing Agents,Agent, Oxidizing,Agents, Oxidizing
D030421 Peroxynitrous Acid A potent oxidant synthesized by the cell during its normal metabolism. Peroxynitrite is formed from the reaction of two free radicals, NITRIC OXIDE and the superoxide anion (SUPEROXIDES). Peroxynitrite,Peroxonitrite,Peroxynitrous Acid, Potassium Salt,Acid, Peroxynitrous,Acids, Peroxynitrous,Peroxonitrites,Peroxynitrites,Peroxynitrous Acids

Related Publications

László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
August 1994, Science (New York, N.Y.),
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
July 2008, The American journal of pathology,
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
April 1999, Trends in pharmacological sciences,
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
January 2006, Current pharmaceutical design,
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
February 1997, FEBS letters,
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
December 2003, Free radical biology & medicine,
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
December 1999, Brain research,
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
December 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
June 2015, The Journal of pharmacology and experimental therapeutics,
László Virág, and Eva Szabó, and Edina Bakondi, and Péter Bai, and Pál Gergely, and János Hunyadi, and Csaba Szabó
February 2003, Current medicinal chemistry,
Copied contents to your clipboard!